Treatment Set TS332080

Product NDC

49288-0702

11-digit product format

492880702

Labeler code

49288

Product ID

49288-0702_89f9e682-acd9-4cc7-982d-c32f69b33b07

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Treatment Set TS332080

Dosage form

INJECTION, SOLUTION

Route

INTRADERMAL; SUBCUTANEOUS

Labeler

Antigen Laboratories, Inc.

Application

BLA102223

Marketing category

BLA

Marketing start

1986-10-31

Marketing end

0000-00-00

Substance

ACER NEGUNDO POLLEN; POA PRATENSIS POLLEN; CYNODON DACTYLON POLLEN; SORGHUM HALEPENSE POLLEN; FRAXINUS AMERICANA POLLEN; QUERCUS ALBA POLLEN; POPULUS DELTOIDES POLLEN

Active strength

0 g/mL; [BAU]/mL; [BAU]/mL; g/mL; g/mL; g/mL; g/mL

Pharmacologic classes

Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]

NDC exclude flag

E

Listing certified through

2017-12-31

Current FDA listing

Historical FDA.report record